{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:47:34Z","timestamp":1790729254077,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05307-3","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:53:05Z","timestamp":1761202385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SUV-max of 68Ga-DOTATATE PET\/CT correlates with WHO grade and RNA risk classification in meningioma"],"prefix":"10.1007","volume":"176","author":[{"given":"Leihao","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juefeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louman","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Wakimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"5307_CR1","doi-asserted-by":"publisher","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","volume":"26","author":"M Price","year":"2024","unstructured":"Price M, Ballard C, Benedetti J, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS, Ostrom QT (2024) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2017\u20132021. Neuro Oncol 26:vi1\u2013vi85. https:\/\/doi.org\/10.1093\/neuonc\/noae145","journal-title":"Neuro Oncol"},{"key":"5307_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"5307_CR3","doi-asserted-by":"publisher","first-page":"i18","DOI":"10.1093\/neuonc\/noy136","volume":"21","author":"PK Brastianos","year":"2019","unstructured":"Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR, International Consortium on M (2019) Advances in multidisciplinary therapy for meningiomas. Neuro Oncol 21:i18\u2013i31. https:\/\/doi.org\/10.1093\/neuonc\/noy136","journal-title":"Neuro Oncol"},{"key":"5307_CR4","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, Preusser M, Minniti G, Lund-Johansen M, Lefranc F, Houdart E, Sallabanda K, Le Rhun E, Nieuwenhuizen D, Tabatabai G, Soffietti R, Weller M (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23:1821\u20131834. https:\/\/doi.org\/10.1093\/neuonc\/noab150","journal-title":"Neuro Oncol"},{"key":"5307_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11060-022-04034-3","volume":"161","author":"L Ren","year":"2023","unstructured":"Ren L, Hua L, Bao Z, Deng J, Wang D, Chen J, Chen H, Juratli TA, Wakimoto H, Gong Y (2023) Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype. J Neurooncol 161:193\u2013202. https:\/\/doi.org\/10.1007\/s11060-022-04034-3","journal-title":"J Neurooncol"},{"key":"5307_CR6","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3171\/2017.2.JNS162566","volume":"128","author":"L Hua","year":"2018","unstructured":"Hua L, Zhu H, Li J, Tang H, Kuang D, Wang Y, Tang F, Chen X, Zhou L, Xie Q, Gong Y (2018) Prognostic value of Estrogen receptor in WHO grade III meningioma: a long-term follow-up study from a single institution. J Neurosurg 128:1698\u20131706. https:\/\/doi.org\/10.3171\/2017.2.JNS162566","journal-title":"J Neurosurg"},{"key":"5307_CR7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1227\/neu.0000000000002272","volume":"92","author":"L Ren","year":"2023","unstructured":"Ren L, Hua L, Deng J, Cheng H, Wang D, Chen J, Xie Q, Wakimoto H, Gong Y (2023) Favorable Long-Term outcomes of chordoid meningioma compared with the other WHO grade 2 meningioma subtypes. Neurosurgery 92:745\u2013755. https:\/\/doi.org\/10.1227\/neu.0000000000002272","journal-title":"Neurosurgery"},{"key":"5307_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3171\/2016.11.JNS161170","volume":"129","author":"L Rogers","year":"2018","unstructured":"Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Brachman D, Jenrette JM, De Groot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP (2018) Intermediate-risk meningioma: initial outcomes from NRG oncology RTOG 0539. J Neurosurg 129:35\u201347. https:\/\/doi.org\/10.3171\/2016.11.JNS161170","journal-title":"J Neurosurg"},{"key":"5307_CR9","doi-asserted-by":"publisher","first-page":"vdab012","DOI":"10.1093\/noajnl\/vdab012","volume":"3","author":"SS Mahase","year":"2021","unstructured":"Mahase SS, Roth O\u2019Brien DA, No D, Roytman M, Skafida ME, Lin E, Karakatsanis NA, Osborne JR, Brandmaier A, Pannullo SC, Ramakrishna R, Stieg PE, Knisely JPS, Ivanidze J (2021) [(68)Ga]-DOTATATE PET\/MRI as an adjunct imaging modality for radiation treatment planning of meningiomas. Neurooncol Adv 3:vdab012. https:\/\/doi.org\/10.1093\/noajnl\/vdab012","journal-title":"Neurooncol Adv"},{"key":"5307_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/jon.12632","volume":"29","author":"J Ivanidze","year":"2019","unstructured":"Ivanidze J, Roytman M, Lin E, Magge RS, Pisapia DJ, Liechty B, Karakatsanis N, Ramakrishna R, Knisely J, Schwartz TH, Osborne JR, Pannullo SC (2019) Gallium-68 DOTATATE PET in the evaluation of intracranial meningiomas. J Neuroimaging 29:650\u2013656. https:\/\/doi.org\/10.1111\/jon.12632","journal-title":"J Neuroimaging"},{"key":"5307_CR11","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.2967\/jnumed.117.191932","volume":"58","author":"WG Kunz","year":"2017","unstructured":"Kunz WG, Jungblut LM, Kazmierczak PM, Vettermann FJ, Bollenbacher A, Tonn JC, Schichor C, Rominger A, Albert NL, Bartenstein P, Reiser MF, Cyran CC (2017) Improved detection of transosseous meningiomas using (68)Ga-DOTATATE PET\/CT compared with Contrast-Enhanced MRI. J Nucl Med 58:1580\u20131587. https:\/\/doi.org\/10.2967\/jnumed.117.191932","journal-title":"J Nucl Med"},{"key":"5307_CR12","doi-asserted-by":"publisher","first-page":"i44","DOI":"10.1093\/neuonc\/noy143","volume":"21","author":"RY Huang","year":"2019","unstructured":"Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Foug\u00e8re C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G, Dunn IF (2019) Imaging and diagnostic advances for intracranial meningiomas. Neuro Oncol 21:i44\u2013i61. https:\/\/doi.org\/10.1093\/neuonc\/noy143","journal-title":"Neuro Oncol"},{"key":"5307_CR13","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/neuonc\/nox101","volume":"19","author":"M Nowosielski","year":"2017","unstructured":"Nowosielski M, Galldiks N, Iglseder S, Kickingereder P, von Deimling A, Bendszus M, Wick W, Sahm F (2017) Diagnostic challenges in meningioma. Neuro Oncol 19:1588\u20131598. https:\/\/doi.org\/10.1093\/neuonc\/nox101","journal-title":"Neuro Oncol"},{"key":"5307_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/WCO.0b013e328340441e","volume":"23","author":"DC Weber","year":"2010","unstructured":"Weber DC, Lovblad KO, Rogers L (2010) New pathology classification, imagery techniques and prospective trials for meningiomas: the future looks bright. Curr Opin Neurol 23:563\u2013570. https:\/\/doi.org\/10.1097\/WCO.0b013e328340441e","journal-title":"Curr Opin Neurol"},{"key":"5307_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s002590050034","volume":"27","author":"JC Reubi","year":"2000","unstructured":"Reubi JC, Schar JC, Waser B, Wenger S, Heppeler A, Schmitt JS, Macke HR (2000) Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 27:273\u2013282. https:\/\/doi.org\/10.1007\/s002590050034","journal-title":"Eur J Nucl Med"},{"key":"5307_CR16","first-page":"13185","volume":"8","author":"CB Silva","year":"2015","unstructured":"Silva CB, Ongaratti BR, Trott G, Haag T, Ferreira NP, Leaes CG, Pereira-Lima JF, Oliveira Mda C (2015) Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance. Int J Clin Exp Pathol 8:13185\u201313192","journal-title":"Int J Clin Exp Pathol"},{"key":"5307_CR17","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1158\/1078-0432.Ccr-20-3362","volume":"27","author":"A Bashir","year":"2021","unstructured":"Bashir A, Larsen VA, Ziebell M, Fugleholm K, Law I (2021) Improved detection of postoperative residual meningioma with [(68)Ga]Ga-DOTA-TOC PET imaging using a High-resolution research tomograph PET scanner. Clin Cancer Res 27:2216\u20132225. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-3362","journal-title":"Clin Cancer Res"},{"key":"5307_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/jlcr.3227","volume":"57","author":"J Aerts","year":"2014","unstructured":"Aerts J, Ballinger JR, Behe M, Decristoforo C, Elsinga PH, Faivre-Chauvet A, Mindt TL, Kolenc Peitl P, Todde SC, Koziorowski J, European Association of Nuclear M (2014) Guidance on current good radiopharmacy practice for the small-scale Preparation of radiopharmaceuticals using automated modules: a European perspective. J Label Comp Radiopharm 57:615\u2013620. https:\/\/doi.org\/10.1002\/jlcr.3227","journal-title":"J Label Comp Radiopharm"},{"key":"5307_CR19","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1007\/s00259-022-05738-4","volume":"49","author":"N Gillings","year":"2022","unstructured":"Gillings N, Hjelstuen O, Behe M, Decristoforo C, Elsinga PH, Ferrari V, Kiss OC, Kolenc P, Koziorowski J, Laverman P, Mindt TL, Ocak M, Patt M, Todde S, Walte A (2022) EANM guideline on quality risk management for radiopharmaceuticals. Eur J Nucl Med Mol Imaging 49:3353\u20133364. https:\/\/doi.org\/10.1007\/s00259-022-05738-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5307_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00259-004-1708-5","volume":"32","author":"F Jacobs","year":"2005","unstructured":"Jacobs F, Thierens H, Piepsz A, Bacher K, Van de Wiele C, Ham H, Dierckx RA, European Association of Nuclear M (2005) Optimised tracer-dependent dosage cards to obtain weight-independent effective doses. Eur J Nucl Med Mol Imaging 32:581\u2013588. https:\/\/doi.org\/10.1007\/s00259-004-1708-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5307_CR21","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1038\/s41591-023-02586-z","volume":"29","author":"WC Chen","year":"2023","unstructured":"Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci AO, Klisch TJ, Nguyen MP, Vasudevan HN, McCortney K, Yu TJ, Bhave V, Lam TC, Pu JK, Li LF, Leung GK, Chan JW, Perlow HK, Palmer JD, Haberler C, Berghoff AS, Preusser M, Nicolaides TP, Mawrin C, Agnihotri S, Resnick A, Rood BR, Chew J, Young JS, Boreta L, Braunstein SE, Schulte J, Butowski N, Santagata S, Spetzler D, Bush NAO, Villanueva-Meyer JE, Chandler JP, Solomon DA, Rogers CL, Pugh SL, Mehta MP, Sneed PK, Berger MS, Horbinski CM, McDermott MW, Perry A, Bi WL, Patel AJ, Sahm F, Magill ST, Raleigh DR (2023) Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nat Med 29:3067\u20133076. https:\/\/doi.org\/10.1038\/s41591-023-02586-z","journal-title":"Nat Med"},{"key":"5307_CR22","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","volume":"44","author":"MF Bozkurt","year":"2017","unstructured":"Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C, Ambrosini V, Kjaer A, Delgado-Bolton R, Kunikowska J, Oyen WJG, Chiti A, Giammarile F, Sundin A, Fanti S (2017) Guideline for PET\/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA. Eur J Nucl Med Mol Imaging 44:1588\u20131601. https:\/\/doi.org\/10.1007\/s00259-017-3728-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5307_CR23","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1097\/rlu.0000000000002183","volume":"43","author":"JE Villanueva-Meyer","year":"2018","unstructured":"Villanueva-Meyer JE, Magill ST, Lee JC, Umetsu SE, Flavell RR (2018) Detection of metastatic meningioma to the liver using 68Ga-DOTA-Octreotate PET\/CT. Clin Nucl Med 43:e338\u2013e340. https:\/\/doi.org\/10.1097\/rlu.0000000000002183","journal-title":"Clin Nucl Med"},{"key":"5307_CR24","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1097\/rlu.0000000000001620","volume":"42","author":"LYI Yamaga","year":"2017","unstructured":"Yamaga LYI, Wagner J, Funari MBG (2017) 68Ga-DOTATATE PET\/CT in nonneuroendocrine tumors: A pictorial essay. Clin Nucl Med 42:e313\u2013e316. https:\/\/doi.org\/10.1097\/rlu.0000000000001620","journal-title":"Clin Nucl Med"},{"key":"5307_CR25","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1097\/rlu.0000000000003012","volume":"45","author":"A Bashir","year":"2020","unstructured":"Bashir A, Broholm H, Clasen-Linde E, Vestergaard MB, Law I (2020) Pearls and pitfalls in interpretation of 68Ga-DOTATOC PET imaging. Clin Nucl Med 45:e279\u2013e280. https:\/\/doi.org\/10.1097\/rlu.0000000000003012","journal-title":"Clin Nucl Med"},{"key":"5307_CR26","doi-asserted-by":"publisher","first-page":"e499","DOI":"10.1097\/rlu.0000000000002594","volume":"44","author":"B Yilmaz","year":"2019","unstructured":"Yilmaz B, Arslan HS, Gundogan C, Gunes MN, Cermik TF (2019) False-Positive 68Ga-DOTATATE PET\/CT in active chronic prostatitis. Clin Nucl Med 44:e499\u2013e500. https:\/\/doi.org\/10.1097\/rlu.0000000000002594","journal-title":"Clin Nucl Med"},{"key":"5307_CR27","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1016\/s1470-2045(17)30078-5","volume":"18","author":"A Braat","year":"2017","unstructured":"Braat A, Goldschmeding R, Brosens LAA, Vriens MR, de Keizer B (2017) Gastrointestinal stromal tumour detection with somatostatin receptor imaging, (68)Ga-HA-DOTATATE PET-CT. Lancet Oncol 18:e185. https:\/\/doi.org\/10.1016\/s1470-2045(17)30078-5","journal-title":"Lancet Oncol"},{"key":"5307_CR28","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1053\/j.gastro.2017.11.008","volume":"154","author":"A Tirosh","year":"2018","unstructured":"Tirosh A, Papadakis GZ, Millo C, Hammoud D, Sadowski SM, Herscovitch P, Pacak K, Marx SJ, Yang L, Nockel P, Shell J, Green P, Keutgen XM, Patel D, Nilubol N, Kebebew E (2018) Prognostic utility of total (68)Ga-DOTATATE-Avid tumor volume in patients with neuroendocrine tumors. Gastroenterology 154:998\u20131008e1001. https:\/\/doi.org\/10.1053\/j.gastro.2017.11.008","journal-title":"Gastroenterology"},{"key":"5307_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1148\/radiol.13122501","volume":"270","author":"AR Haug","year":"2014","unstructured":"Haug AR, Cindea-Drimus R, Auernhammer CJ, Reincke M, Beuschlein F, W\u00e4ngler B, Uebleis C, Schmidt GP, Spitzweg C, Bartenstein P, Hacker M (2014) Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET\/CT. Radiology 270:517\u2013525. https:\/\/doi.org\/10.1148\/radiol.13122501","journal-title":"Radiology"},{"key":"5307_CR30","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3389\/fonc.2020.01144","volume":"10","author":"GTC de Carvalho","year":"2020","unstructured":"de Carvalho GTC, da Silva-Martins WC, de Magalh\u00e3es K, Nunes CB, Soares AN, Tafuri LSA, Sim\u00f5es RT (2020) Recurrence\/Regrowth in grade I meningioma: how to predict? Front Oncol 10:1144. https:\/\/doi.org\/10.3389\/fonc.2020.01144","journal-title":"Front Oncol"},{"key":"5307_CR31","doi-asserted-by":"publisher","first-page":"846232","DOI":"10.3389\/fonc.2022.846232","volume":"12","author":"AM Roehrkasse","year":"2022","unstructured":"Roehrkasse AM, Peterson JEG, Fung KM, Pelargos PE, Dunn IF (2022) The discrepancy between standard histologic WHO grading of meningioma and molecular profile: A single institution series. Front Oncol 12:846232. https:\/\/doi.org\/10.3389\/fonc.2022.846232","journal-title":"Front Oncol"},{"key":"5307_CR32","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1007\/s00259-022-05848-z","volume":"49","author":"V Rufini","year":"2022","unstructured":"Rufini V, Lorusso M, Inzani F, Pasciuto T, Triumbari EKA, Grillo LR, Locco F, Margaritora S, Pescarmona E, Rindi G (2022) Correlation of somatostatin receptor PET\/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study. Eur J Nucl Med Mol Imaging 49:4182\u20134193. https:\/\/doi.org\/10.1007\/s00259-022-05848-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5307_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41824-024-00193-w","volume":"8","author":"F Weitzer","year":"2024","unstructured":"Weitzer F, Stanzel S, Plhak E, Aigner RM (2024) Clinical value of semi-quantitative parameters in (68)Ga-DOTANOC PET\/CT in treatment and diagnostics of cranial meningioma in a single-center retrospective analysis. EJNMMI Rep 8:10. https:\/\/doi.org\/10.1186\/s41824-024-00193-w","journal-title":"EJNMMI Rep"},{"key":"5307_CR34","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/neuonc\/noae067","volume":"26","author":"J Ivanidze","year":"2024","unstructured":"Ivanidze J, Chang SJ, Haghdel A, Kim JT, Roy Choudhury A, Wu A, Ramakrishna R, Schwartz TH, Cisse B, Stieg P, Muller L, Osborne JR, Magge RS, Karakatsanis NA, Roytman M, Lin E, Pannullo SC, Palmer JD, Knisely JPS (2024) [Ga68] DOTATATE PET\/MRI-guided radiosurgical treatment planning and response assessment in meningiomas. Neuro Oncol 26:1526\u20131535. https:\/\/doi.org\/10.1093\/neuonc\/noae067","journal-title":"Neuro Oncol"},{"key":"5307_CR35","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/neuonc\/now001","volume":"18","author":"M Sommerauer","year":"2016","unstructured":"Sommerauer M, Burkhardt JK, Frontzek K, Rushing E, Buck A, Krayenbuehl N, Weller M, Schaefer N, Kuhn FP (2016) 68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate? Neuro Oncol 18:1021\u20131027. https:\/\/doi.org\/10.1093\/neuonc\/now001","journal-title":"Neuro Oncol"},{"key":"5307_CR36","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.2967\/jnumed.116.186361","volume":"58","author":"L Bodei","year":"2017","unstructured":"Bodei L, Ambrosini V, Herrmann K, Modlin I (2017) Current concepts in (68)Ga-DOTATATE imaging of neuroendocrine neoplasms: Interpretation, Biodistribution, Dosimetry, and molecular strategies. J Nucl Med 58:1718\u20131726. https:\/\/doi.org\/10.2967\/jnumed.116.186361","journal-title":"J Nucl Med"},{"key":"5307_CR37","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/neuonc\/nou131","volume":"17","author":"A Afshar-Oromieh","year":"2015","unstructured":"Afshar-Oromieh A, Wolf MB, Kratochwil C, Giesel FL, Combs SE, Dimitrakopoulou-Strauss A, Gnirs R, Roethke MC, Schlemmer HP, Haberkorn U (2015) Comparison of \u2076\u2078Ga-DOTATOC-PET\/CT and PET\/MRI hybrid systems in patients with cranial meningioma: initial results. Neuro Oncol 17:312\u2013319. https:\/\/doi.org\/10.1093\/neuonc\/nou131","journal-title":"Neuro Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05307-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05307-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05307-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:34:25Z","timestamp":1767702865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05307-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5307"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05307-3","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Huashan hospital ethics committee (KY2022-049).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patient consent was waived due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Supplementary Fig.\u00a0\n                      \n                      a,\n                      \n                      b and\n                      \n                      c.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}